Skip to main content

Table 2 Comparison of general material and biochemical indexes of each subgroup

From: Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients

  T2DM with NAFLD (n = 231) Simple T2DM (n = 108) P value
NFS < 0.676(n = 183) NFS ≥ 0.676(n = 48)
Sex (male/female) 107/76 27/21 58/50 0.729
Age (years) 54.4 ± 10.9## 67.9 ± 11.2** 63.2 ± 10.8 0.000
Diabetic duration (years) 7.0 (3.0–12.0)## 11.0 (7.0–17.0)** 10.0 (5.0–15.0) 0.000
BMI (kg/m2) 26.60 ± 3.27## 27.93 ± 3.14* 24.69 ± 3.38 0.000
Systolic pressure(mmHg) 132 (122–144) 133 (123–155) 132 (120–152) 0.330
Diastolic pressure(mmHg) 83.2 ± 9.6 81.1 ± 12.0 82.1 ± 10.2 0.374
Waistline(cm) 93 (87–99)## 96 (90–101) 90 (85–95) 0.000
ALT(U/L) 21 (16–32)## 18 (13–30)* 15 (12–22) 0.000
AST(U/L) 18 (15–22) 20 (16–27)* 17 (14–21) 0.006
GGT (U/L) 31.0 (22.0–49.0)## 25.5 (18.0–42.8) 18.5 (13.0–28.0) 0.000
CR (umol/L) 56.0 (47.6–65.1)## 64.2 (53.7–79.9)** 62.8 (49.8–72.3) 0.000
UA (umol/L) 315.5 ± 91.9 356.9 ± 82.7** 304.1 ± 101.6 0.005
CysC (mg/L) 0.88 (0.79–0.98)## 1.09 (0.93–1.37)** 0.97 (0.83–1.17) 0.000
FBG (mmol/L) 8.21 (6.55–11.35)## 7.59 (5.70–9.89) 6.86 (5.59–9.84) 0.003
TG (mmol/L) 1.98 (1.31–2.84)## 1.68 (1.12–2.64) 1.20 (0.89–1.58) 0.000
TC (mmol/L) 4.90 ± 1.12# 4.69 ± 1.02 4.56 ± 1.21 0.037
HDL (mmol/L) 1.01 (0.86–1.17)## 1.05 (0.85–1.30) 1.10 (0.98–1.39) 0.000
LDL (mmol/L) 2.90 ± 0.83 2.81 ± 0.85 2.69 ± 1.04 0.167
HOMA-IR (CP) 3.90 (3.10–5.13)## 3.67 (3.06–4.54) 2.82 (2.45–3.67) 0.000
HBA1C (%) 8.7 (7.2–9.9) 8.2 (6.9–9.5) 7.7 (6.6–9.5) 0.042
25-(OH) D (ng/mL) 14.92 (11.72–18.64)# 13.97 (11.21–15.86)* 16.21 (12.22–22.59) 0.005
  1. The measured data of the normal distribution was represented by mean ± SD. Measurement data for non-normal distributions were expressed as medians (interquartile intervals).*p < 0.05, **p < 0.01, T2DM with NFS ≥ 0.676 vs T2DM with NFS < 0.676; p < 0.05, p < 0.01,T2DM with NFS ≥ 0.676 vs Simple T2DM;#p < 0.05, ##p < 0.01, T2DM with NFS < 0.676 vs Simple T2DM
  2. Note: NAFLD Nonalcoholic fatty liver disease, T2DM Type 2 diabetes mellitus, BMI Body mass index, NFS NAFLD fibrosis score, ALT Alanine aminotransferase, AST Aspartic acid aminotransferase, GGT Glutamyltransferase, CR Creatinine, UA Uric acid, CysC Cystatin c, FBG Fasting blood glucose, TG Triglyceride, TC Total cholesterol, HDL High density lipoprotein, LDL Low density lipoprotein, Homa-IR (CP) Homeostasis model assessment for insulin resistance(C-peptide), HbA1c Glycosylatedhemoglobin, 25-(OH) D 25- hydroxyvitamin D